Denali Therapeutics (4DN.F) Q3 2024 Earnings

Aug 1Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.79
-0.71
-0.63
-0.55

Details

Expected EPS
-0.65100943875
Actual EPS
-0.5467825
Surprise EPS
0.1
Surprise Percent
+16.01%

Description

⁨Denali Therapeutics⁩ (⁦4DN.F⁩) has reported earnings of ⁦-0.5467825⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts